glutathione level mda mb 468 Frontiers Frontiers | Compounds targeting ferroptosis
Frontiers Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential Discovery of Novel Potent Covalent Glutathione Peroxidase 4 Inhibitors as Highly Selective Ferroptosis Inducers for the Treatment of Triple Negative Breast Cancer Journal of Medicinal Chemistry The oncoprotein MUC1 facilitates breast cancer progression by promoting Pink1 dependent mitophagy via ATAD3A destabilization Cell Death & Disease A marine derived small molecule induces immunogenic cell death against triple negative breast cancer through ER stress CHOP pathway MDA MB 468 AcceGen Mediator kinase inhibitors suppress triple negative breast cancer growth and extend tumor suppression by mTOR and AKT inhibitors PNAS
Pay in 4 interest-free payments of $6.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





